New Gene Therapy Methods Accurately Correct Mutation In Patient’s Stem Cells, Bringing Personalized Cell Therapies One Step Closer

Friday, October 14th, 2011

For the first time, scientists have cleanly corrected a human gene mutation in a patient's stem cells. The result, reported in Nature, brings the possibility of patient-specific therapies closer to becoming a reality. The team, led by researchers from the Wellcome Trust Sanger Institute and the University of Cambridge, targeted ...

Cleveland Area Brain Cancer Patients Now Testing Revolutionary Personalized Immune Therapy For Cancer

Friday, July 22nd, 2011

A ground-breaking new treatment in late-stage clinical trials is giving Cleveland area patients new hope in their battle against one of the most lethal forms of cancer: Glioblastoma multiforme (GBM) brain cancer. The DCVax®-L personalized cancer immune therapy (a therapeutic "cancer vaccine"), which has been under development by ...

Virtual Surgery Shows Promise In Personalized Treatment Of Nasal Obstruction

Monday, April 18th, 2011

A preliminary report suggests that virtual nasal surgery has the potential to be a productive tool that may enable surgeons to perform personalized nasal surgery using computer simulation techniques, according to a report posted online today that will appear in the September print issue of Archives of Facial Plastic Surgery, ...

Proteomics Research Heading Towards Personalized Treatments For Cancer, Diabetes And Inflammatory Diseases

Sunday, March 27th, 2011

NeoProteomics Inc., a biomarker development and software company, has secured an exclusive option agreement with Case Western Reserve University. The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases. Proteomics is the scientific next step in vital research of protein structures of biological systems. ...

Protagen At The Personalized Medicine And Diagnostics Europe Congress 2011, 9-10 March

Monday, January 31st, 2011

Protagen AG, a specialist for GMP-compliant protein analysis and in-vitro diagnostics is presenting at the Personalized Medicine and Diagnostics Europe Congress in London. Dr. Stefan Mullner, CEO of Protagen AG will discuss the latest achievements in personalized medicine together with an expert panel of representatives from pharma, biotech and diagnostic. ...